Thus, miR34a is a crucial factor in mediating activated TP53 response and, the fact that it is often deleted or down-regulated in human cancers indicates its tumor suppressive effect and makes it a valuable prognostic marker15–19. The gene discussed is TP53; the disease is neoplasm.